4-Hydroxy-6-(phenylamino)naphthalene-2-sulfonic acid, 98%, 25g

2-methylthieno[3',2':5,6]benzo[1,2-d]thiazol-5-ol, 95.0%, 2.5g

(6S)-4-OXO-5-AZASPIRO[2.4]HEPTANE-6-CARBOXYLIC ACID, 95.0%, 500mg

2-Butoxy-5-iodonicotinic acid, 95.0%, 5g

2-(tert-butyl)-5-methyl-2,4-dihydro-3H-pyrazol-3-one, 95.0%, 500mg

Recipiente de reacción con brida plana, cilíndrico, graduado, con camisa de templado y vacío y válvula de drenaje, DN 100, 4000 ml, 250 mm, 1 pieza

1,3-Bis(vinylsulfonyl)propan-2-ol, 95.0%, 250mg

(2R)-4-OXOAZETIDINE-2-CARBOXYLIC ACID, 95.0%, 100mg

(S)-1-(4-(Difluoromethoxy)phenyl)ethan-1-amine hydrochloride, 95%, 250mg

(S)-(-)-1-(2-NAPHTHYL)ETHANOL, 95%, 5g

Dipropylene glycol, mixture of isomers, 100g

(3-HYDROXYBENZOYLAMINO)ACETIC ACID, 97.0%, 1g

3,5-Dibromo-2-(trifluoromethyl)pyridine, 95+%, 1g